The porphyrias are a group of eight disorders of haem biosynthesis characterised by overproduction of haem precursors secondary to partial enzyme deficiencies or, in one porphyria, gain of function of the rate‐controlling enzyme of the pathway in erythroid cells. Patients suffer from acute neurovisceral attacks, always associated with overproduction of porphyrin precursors, skin lesions caused by photosensitisation by porphyrins or both together. All are inherited, apart from sporadic porphyria cutanea tarda. The three porphyrias in which acute attacks occur (acute intermittent porphyria, hereditary coproporphyria and variegate porphyria) and familial porphyria cutanea tarda are low penetrance autosomal dominant disorders and one is an X‐linked disorder. All others are autosomal recessive. Enzyme activities in the autosomal recessive porphyrias and in the homozygous variants of other porphyrias are usually less than 20% of normal.

Key Concepts

  • The porphyrias are disorders of haem biosynthesis.
  • Each of the eight porphyrias is caused by an abnormality of a different enzyme of haem biosynthesis.
  • Each enzyme abnormality leads to overproduction of haem precursors in a specific pattern that defines the disorder.
  • Overproduction of porphyrin precursors leads to acute neurovisceral attacks that characterise the three autosomal dominant acute porphyrias and one rare recessive porphyria.
  • Overproduction of porphyrins leads to photosensitisation of the skin with either skin fragility and blisters or, when only protoporphyrin accumulates, acute painful photosensitivity.
  • All autosomal dominant porphyrias have low clinical penetrance.
  • Most patients with the commonest inherited cutaneous porphyria, erythropoietic protoporphyria, have inherited a low expression ferrochelatase allele trans to a deleterious ferrochelatase mutation.
  • The prevalence of erythropoietic protoporphyria and the proportion of families showing pseudo‐dominant inheritance are determined by the population frequency of the low expression allele.

Keywords: porphyria; haem; autosomal dominant; autosomal recessive; penetrance; X‐linked dominant

Figure 1. Pathway of haem biosynthesis. Hydroxymethylbilane (HMB) also undergoes non‐enzymatic cyclisation to uroporphyrinogen I, which may be converted to coproporphyrinogen I but is not metabolised further; unless UROS is deficient, less than 1% of HMB follows this route. Porphyrinogens are rapidly oxidised to porphyrins within tissues and during excretion. Alternative names for ALAD and PBGD are PBG synthase and HMB synthase, respectively.
Figure 2. Letters denote FECH alleles: A, normal; B, severe mutation and C, low expression. Arrow indicates individual with clinically overt EPP.


Anderson KE, Sassa S, Bishop D and Desnick RJ (2001) Disorders of heme biosynthesis: X‐linked sideroblastic anemia and the porphyrias. In: Scriver CR, Beaudet AL, Sly WS and Valle D, (eds); Childs B, Kinzler KW, Vogelstein B (assoc eds). The Metabolic and Molecular Bases of Inherited Disease, 8th edn, pp. 2961–3062. New York: McGraw‐Hill.

Barman‐Aksözen J, Minder EI, Schubiger C, Biolcati G and Schneider‐Yin X (2014 Aug 29) In ferrochelatase‐deficient protoporphyria patients, ALAS2 expression is enhanced and erythrocytic protoporphyrin concentration correlates with iron availability. Blood Cells, Molecules and Diseases pii: S1079‐9796(14)00096‐5. DOI: 10.1016/j.bcmd.2014.07.017 [Epub ahead of print].

Bonkovsky HL, Guo JT, Hou W, Li T and Narang T (2013 Jan) Thapar M Porphyrin and heme metabolism and the porphyrias. Comprehensive Physiology 3 (1): 365–401.

Bonkovsky HL, Maddukuri VC, Yazici C, et al. (2014 Jul 9) Acute porphyrias in the USA: features of 108 subjects from Porphyria Consortium. American Journal of Medicine. DOI: 10.1016/j.amjmed.2014.06.036 [Epub ahead of print].

Bossi K, Lee J, Schmeltzer P, et al. (2014) Homeostasis of iron and hepcidin in erythropoietic protoporphyria and X‐linked protoporphyria. American Journal of Gastroenterology 109 (Suppl 2): S180.

Beutler E (2006) Hemochromatosis. eLS. Chichester: John Wiley & Sons Ltd. http://www.els.net [Doi: 10.1038/npg.els.0005530].

Chen B, Hakenberg J, Srinivasan RR, et al. (2014) Acute intermittent porphyria: high incidence of pathogenic HMB‐Synthase (HMBS) non‐synonymous SNPs (nsSNPs) in genomic databases suggests other genetic and environmental factors cause the acute attacks. Hepatology 60 (4, suppl): 426A–427A.

Craig AD and Sorkin LS (Mar 2011) Pain and analgesia. In: eLS. Chichester: John Wiley & Sons Ltd http://www.els.net [Doi: 10.1002/9780470015902.a0000275.pub3].

Dickenson T (2012) Opiates and opioids. eLS. Chichester: John Wiley & Sons Ltd. http://www.els.net [Doi: 10.1002/9780470015902.a0000251.pub2].

Drew PD and Ades IZ (1989) Regulation of the stability of chicken embryo liver delta‐aminolevulinate synthase mRNA by hemin. Biochemical and Biophysical Research Communications 162: 102–107.

Fritsch C, Bolsen K, Ruzicka T and Gunter G (1997) Congenital erythropoietic porphyria. Journal of the American Academy of Dermatology 36: 594–610.

Grandchamp B (1998) Acute intermittent porphyria. Seminars in Liver Disease 18: 17–24.

Herrington MB (2013) Nonsense mutations and suppression. eLS. Chichester: John Wiley & Sons Ltd. http://www.els.net [Doi: 10.1002/9780470015902.a0000824.pub2].

Gouya L, Puy H, Robreau AM, et al. (2002) The penetrance of autosomal dominant erythropoietic protoporphyria is modulated by expression of wild type FECH. Nature Genetics 30: 27–28.

Lathrop JT and Timko MP (1993) Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. Science 259: 522–525.

Lyonnet S, Feingold J and Frézal J (2006) Genotype‐phenotype relationships. eLS. Chichester: John Wiley & Sons Ltd. http://www.els.net [Doi: 10.1002/9780470015902.a0005476].

Meyer UA, Schuurmans MM and Lindberg RLP (1998) Acute porphyrias: pathogenesis of neurological manifestations. Seminars in Liver Disease 18: 43–52.

Mustajoki P and Nordmann Y (1993) Early administration of heme arginate for acute porphyric attacks. Archives of Internal Medicine 153: 2004–2008.

Nordmann Y, Puy H, DaSilva V, et al. (1997) Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France. Journal of Internal Medicine 242: 213–217.

Ponka P (1997) Tissue‐specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 89: 1–25.

Scriver CR (2006) Allelic and locus heterogeneity. eLS. Chichester: John Wiley & Sons Ltd. http://www.els.net [Doi: 10.1038/npg.els.0005481].

Tian Q, Li T, Hou W, et al. (2011 Jul 29) Lon peptidase 1 (LONP1)‐dependent breakdown of mitochondrial 5‐aminolevulinic acid synthase protein by heme in human liver cells. Journal of Biological Chemistry 286 (30): 26424–26430.

Todd DJ (1994) Erythropoietic protoporphyria. British Journal of Dermatology 131: 751–766.

Yamamoto M, Hayashi N and Kikuchi G (1982) Evidence for the transcriptional inhibition by heme of the synthesis of delta‐aminolevulinate synthase in rat liver. Biochemical and Biophysical Research Communications 105: 985–990.

Yamamoto M, Kure S, Engel JD and Hiraga K (1988) Structure, turnover, and heme‐mediated suppression of the level of mRNA encoding rat liver delta‐aminolevulinate synthase. Journal of Biological Chemistry 263: 15973–15979.

Further Reading

Balwani M and Desnick RJ (2012 Nov 29); The porphyrias: advances in diagnosis and treatment. Blood 120 (23): 4496–4504.

Elder GH, Hift RJ and Meissner PN (1997) The acute porphyrias. Lancet 349: 1613–1617.

Jenkins T (1996) The South African malady. Nature Genetics 13: 7–9.

Puy H, Gouya L and Deybach JC (2010) Porphyrias. Lancet 375 (9718): 924–937.

Rohl JCG, Warren M and Hunt D (1998) Purple Secret: Genes, “Madness” and the Royal Houses of Europe. London: Bantam Press.

Schmid R (ed.) (1998) The porphyrias. Seminars in Liver Disease 18: 1–101.

Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

How to Cite close
Besur, Siddesh, and Bonkovsky, Herbert L(Feb 2015) Porphyrias. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0000565.pub3]